Reversibility of congenital hypogonadotropic hypogonadism: lessons from a rare disease

Affiliations

Comment

Bradley D Anawalt. Lancet Diabetes Endocrinol. 2024 Apr.

. 2024 Apr;12(4):219-221.

doi: 10.1016/S2213-8587(24)00065-2. Epub 2024 Mar 1.

¹ University of Washington School of Medicine, Seattle, WA 98195, USA. Electronic address: banawalt@medicine.washington.edu.

No abstract available

Conflict of interest statement

I declare no competing interests.

Classes and predictors of reversal in male patients with congenital hypogonadotropic hypogonadism: a cross-sectional study of six international referral centres.
Dwyer AA, McDonald IR, Cangiano B, Giovanelli L, Maione L, Silveira LFG, Raivio T, Latronico AC, Young J, Quinton R, Bonomi M, Persani L, Seminara SB, Lee CS. Dwyer AA, et al. Lancet Diabetes Endocrinol. 2024 Apr;12(4):257-266. doi: 10.1016/S2213-8587(24)00028-7. Epub 2024 Mar 1. Lancet Diabetes Endocrinol. 2024. PMID: 38437850 Free PMC article.